(MENAFN- EIN Presswire)
Controlled Release Drug Delivery Global market Size, Share And Growth Analysis For 2024-2033
Controlled Release Drug Delivery Market Size, Share, Revenue , Trends, And Forecast 2024-2033
You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs
” - The Business Research Company
LONDON , GREATER LONDON , UNITED KINGDOM, October 1, 2024 /EINPresswire / -- The controlled release drug delivery market has experienced robust growth in recent years, expanding from $59.2 billion in 2023 to $66.18 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to pioneering drug delivery systems, early polymer-based formulations, introduction of microencapsulation techniques, emergence of transdermal delivery, regulatory approvals, and standardization.
What Is TheEstimated Market Size Of The Global Controlled Release Drug Delivery MarketAnd Its Annual Growth Rate?
The controlled release drug delivery market is projected to continue its strong growth, reaching $105.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to shift towards personalized medicine, technological integration for patient convenience, expansion of biologics and biosimilars, market expansion in developing regions, advancements in polymer science.
Explore Comprehensive Insights Into The Global Controlled Release Drug Delivery Market With A Detailed Sample Report:
Growth Driver OfThe Controlled Release Drug Delivery Market
The rising prevalence of chronic diseases is expected to propel the growth of the controlled release drug delivery market. Chronic diseases are also known as noncommunicable diseases. It refers to conditions such as heart disease, cancer, and diabetes diseases lasting more than a year and requiring continuing medical care, limiting everyday activities, or both. Controlled-release drug delivery is crucial for treating chronic diseases.
Order Your Report Now ForA Swift Delivery:
Which Market Players Are Steering TheControlled Release Drug Delivery Market Growth?
Key players in the market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes PLC, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline PLC, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan PLC, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca PLC, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International PLC, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic PLC, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group PLC, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.
What Are TheKey Trends That Influence Controlled Release Drug Delivery Market Share And Analysis?
Major companies operating in the chocolate syrup market are adopting a strategic partnership approach, aiming to expand ophthalmic applications. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success.
How Is The Global Controlled Release Drug DeliveryMarket Segmented?
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Geographical Insights: North America Leading TheControlled Release Drug DeliveryMarket
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Controlled Release Drug Delivery Market Definition
Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.
Controlled Release Drug Delivery Global Market Report 2024 from TBRC covers the following information:
.Market size data for the forecast period: Historical and Future
.Macroeconomic factors affecting the market in the short and long run
.Analysis of the macro and micro economic factors that have affected the market in the past five years
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
An overview of the global controlled release drug delivery market report covering trends, opportunities, strategies, and more
The Controlled Release Drug Delivery Global Market Report 2024by The Business Research Company is the most comprehensive report that provides insights on controlled release drug delivery market size, controlled release drug delivery market driversand trends, controlled release drug delivery market major playersand controlled release drug delivery market growth across geographies. Thisreport helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Drug Delivery Devices Global Market Report 2024
Drugs for Immunotherapy Global Market Report 2024
Drugs For Benign Prostatic hypertrophy Global Market Report 2024
What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN01102024003118003196ID1108735539